Market closed

INmune Bio/INMB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About INmune Bio

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Ticker

INMB
Trading on

Industry

Biotechnology

Employees

14

INmune Bio Metrics

BasicAdvanced
$121M
Market cap
-
P/E ratio
-$2.06
EPS
1.94
Beta
-
Dividend rate
$121M
1.94
$14.74
$4.81
283K
2.358
2.291
0.868
14.647
-23.01%
-38.66%
-86.04%
1,178.248
2.97
5.44
-4.349
-69.53%
38.86%
78.28%
14.42%

What the Analysts think about INmune Bio

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for INmune Bio stock.

INmune Bio Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

INmune Bio Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy INMB

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for INmune Bio stock?

INmune Bio (INMB) has a market cap of $121M as of October 08, 2024.

What is the P/E ratio for INmune Bio stock?

The price to earnings (P/E) ratio for INmune Bio (INMB) stock is 0 as of October 08, 2024.

Does INmune Bio stock pay dividends?

No, INmune Bio (INMB) stock does not pay dividends to its shareholders as of October 08, 2024.

When is the next INmune Bio dividend payment date?

INmune Bio (INMB) stock does not pay dividends to its shareholders.

What is the beta indicator for INmune Bio?

INmune Bio (INMB) has a beta rating of 1.94. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.